Targeting the SK2 Potassium Channel: Enabling Structure-Based Drug Discovery of Membrane Proteins Through an Integrated cyro-EM Pipeline

9:30 am - Thursday 30th July 2026

  • Integrating rapid construct screening approaches to optimize design, expression, and protein yield
  • Developing robust biophysical assays to validate screening hits and prioritize targets for structural studies
  • Implementing end-to-end cryo-EM workflows including grid preparation and screening, data processing, model building, and structure interpretation

Speakers:

Principal Scientist
Novartis AG